miércoles, 8 de mayo de 2013

What's New at CBER Update

Advancing Regulatory Science

FDA discovery that Ad5 vector uses coagulation factor X to block complement proteins has major implications for gene therapy (PDF - 182KB)
Posted: 5/7/2013
Expanded and improved approach to identifying surface protein markers could support development of therapies with human bone marrow multipotent stromal cells (PDF - 262KB)
Posted: 5/7/2013

No hay comentarios:

Publicar un comentario